Long-Term Liabilities: The sum of all non-current liabilities.
Abeona Therapeutics Inc. (ABEO) had Long-Term Liabilities of $30.78M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$5.42M |
|
$-20.46M |
|
$1.04M |
|
$4.38M |
|
$28.33M |
|
$-22.91M |
|
$2.24M |
|
$-20.68M |
|
$-20.68M |
|
$-20.46M |
|
$-20.46M |
|
$-20.46M |
|
$-20.46M |
|
$-22.91M |
|
$-21.82M |
|
52.95M |
|
66.14M |
|
$-0.39 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$204.91M |
|
$9.92M |
|
$14.66M |
|
$219.57M |
|
$29.57M |
|
$7.81M |
|
|
Long-Term Liabilities |
$30.78M |
$60.35M |
|
$159.22M |
|
$159.22M |
|
$159.22M |
|
55.04M |
|
| Cash Flow Statement Financials | |
$-76.33M |
|
$105.03M |
|
$26.04M |
|
$23.70M |
|
$78.44M |
|
$54.74M |
|
$10.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.93 |
|
-- |
|
-- |
|
0.05 |
|
0.13 |
|
80.74% |
|
-422.71% |
|
-422.71% |
|
-- |
|
-381.46% |
|
-377.49% |
|
$-84.30M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.19 |
|
0.81 |
|
111.50 |
|
-12.85% |
|
-12.85% |
|
-9.32% |
|
-12.25% |
|
$2.89 |
|
$-1.27 |
|
$-1.15 |
|